Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03405389 · ClinicalTrials.gov registry record
Focused Registry to Collect Clinical Data on the MatrixWAVE System
A clinical trial, sponsored by AO Innovation Translation Center.
- Completed
- Registry status
- 44
- Enrollment target
NCT03405389: Completed study, sponsored by AO Innovation Translation Center.
NCT03405389 is a clinical trial that has completed, run by AO Innovation Translation Center. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03405389 has completed, sponsored by AO Innovation Translation Center.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The goal of this registry is to evaluate the performance of the MatrixWAVE(TM) MMF system in patients suffering from non-condylar and/or condylar fractures. The evaluation will focus on the clinical performance in terms of : * surgical technique * application time * intra- and postoperative complications * short term patient-reported outcomes
Primary Outcome
Time required by the surgeons to apply the MatrixWAVE MMF system
Interventions
- PROCEDURE MatrixWAVE MMF System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2025-04-01 |
What the finished NCT03405389 record still lists
NCT03405389 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MatrixWAVE MMF System is the first listed.
NCT03405389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03405389 about?
NCT03405389 is a clinical study titled "Focused Registry to Collect Clinical Data on the MatrixWAVE System". The goal of this registry is to evaluate the performance of the MatrixWAVE(TM) MMF system in patients suffering from non-condylar and/or condylar fractures. The evaluation will focus on the clinical performance in terms of : * surgical technique * application time * intra- and postoperative complic...
What is the current status of trial NCT03405389?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2019-06-20. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT03405389?
The interventions under investigation include: MatrixWAVE MMF System (PROCEDURE).
Who is sponsoring clinical trial NCT03405389?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI